Written By Sasha-Kay Brown
1.1 Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood that can continue into adulthood. ADHD causes problems in how well children and adults do in school, work, or social situations. It is diagnosed by a health care provider based on a physical exam, psychological assessment, and ADHD rating scales.
ADHD is not just a behavioral disorder, it is also a neurological disorder that affects the structure and function of the brain and nervous system. Research has shown that people with ADHD have differences in their brain anatomy, chemistry, activity, and connectivity compared to people with typical development. These differences can explain some of the symptoms and challenges that people with ADHD face in their daily lives.
The purpose of this blog post is to provide an overview of the neurobiology of ADHD and how it affects various aspects of cognition, emotion, and behavior. This blog post will also discuss the implications of these findings for the diagnosis and treatment of ADHD. By understanding the neurological basis of ADHD, we can gain more insight into the strengths and weaknesses of people with ADHD and how to best support them in their personal and professional lives. We can also appreciate the diversity and complexity of human brain development and function.
1.2 Understanding ADHD
ADHD symptoms can be mild, moderate, or severe and may start before age 12. In some children, symptoms are noticeable as early as 3 years of age. There are three subtypes of ADHD: Predominantly inattentive, Predominantly hyperactive/impulsive, and combined. (1)
The prevalence of ADHD varies depending on the source, age group, gender, and region of the population. The DSM-5 states that 5% of children are diagnosed with ADHD, while other studies report a range of 0.1% to 15.5% in children and adolescents. The prevalence of ADHD in adults is estimated to be around 2.5% to 4.4%, with males and non-Hispanic whites having higher rates than females and other race/ethnicity groups. (2)
Common symptoms of ADHD include lack of focus, poor time management skills, disorganization, impulsivity, fits of rage, forgetfulness, lack of motivation, restlessness and anxiety, fatigue, poor self-image, and relationship issues. If untreated for a prolonged period, it may lead to poor school or work performance, unemployment, trouble with the law, alcohol or other substance abuse, frequent car accidents or other accidents, unstable relationships, poor physical and mental health, poor self-image, and suicide attempts. Treatment options for Adult attention deficit hyperactive disorder include drugs (such as Methylphenidate or Amphetamine), talk therapy (such as Psychotherapy or Cognitive behavior therapy), and treatment for associated mental health conditions. (3)
1.3 Neurobiology of ADHD
ADHD is associated with a deficit in two main neurotransmitters: dopamine and norepinephrine. These neurotransmitters are involved in impulse control, focus, decision-making, emotion regulation, and reward processing. ADHD may also affect the levels of serotonin, another neurotransmitter that influences brain function. ADHD symptoms may result from impaired neurotransmitter activity in four regions of the brain: the frontal cortex, the limbic system, the basal ganglia, and the reticular activating system. (4)
The prefrontal cortex is the main area affected by ADHD. This area, located in the front of the brain, is responsible for the brain's executive functions, including focus, problem-solving, working memory, impulse control, prioritization, and initiating tasks. (4) Other regions of the brain that are implicated by ADHD include the orbito-medial prefrontal cortex, right anterior cingulate, right anterior corona radiata, superior and inferior longitudinal fasciculus, limbic regions, basal ganglia, dorsolateral-prefrontal cortex, cerebellar vermis, caudate nucleus, prefrontal cortex white matter and corpus callosum. (5)
ADHD is a disorder that can run in families and is influenced by genetic factors. The genes you inherit from your parents can significantly affect your risk of developing ADHD. If a parent, sibling, or close relative has ADHD, you are more likely to have it as well. However, genes are not the only factor as environmental influences can also play a role. ADHD is associated with some brain differences such as thinner brain tissue or missing DNA. (6) The formal heritability of ADHD is about 80% and therefore higher than most other psychiatric diseases. However recent studies estimate the proportion of heritability based on single-nucleotide variants (SNPs) at 22%. (7)
1.4 Neural Mechanisms of Attention
The brain processes and regulates attention through a distributed system of brain areas that control attention by enhancing and regulating the elaboration of specific aspects of information. These areas include the prefrontal cortex, which selects what information to focus on, the thalamus, which filters out irrelevant sensory inputs, and the limbic regions, which influence emotions and motivation. ADHD-related changes in these areas can contribute to hyperactivity, inattention, and poorer decision-making. (8)
In individuals with ADHD, there are differences in attentional networks compared to individuals without ADHD. For example, in children with ADHD, the frontal-parietal attentional network could possibly be more decentrally organized and less centrally organized. This appears to result in more random connectivity with impaired global efficiency and network decentralization in ADHD. (9)
Neuroimaging studies on attention deficits in ADHD have helped to elucidate the underlying neurobiology of ADHD. These studies suggest that abnormal brain connectivity plays a central role in the pathogenesis of ADHD. (10) Neuroimaging techniques such as magnetic resonance imaging (MRI) have been used to investigate structural and functional differences in the brains of individuals with ADHD compared to those without ADHD. These studies have revealed differences in several brain regions and have highlighted the importance of understanding brain network organization and connectivity in understanding ADHD. (11)
2.1 Hyperactivity and Impulsivity
The neurobiological basis of hyperactivity and impulsivity in ADHD is thought to involve changes in the brain's anatomy and function, particularly in the frontostriatal circuit. The frontostriatal circuit is a neural pathway that connects the prefrontal cortex, which is involved in executive functions such as impulse control, with the basal ganglia, which plays a role in motor control and reward processing. Abnormalities in the frontostriatal connectivity and function have been observed in individuals with ADHD. (12)
In addition to the frontostriatal circuit, other brain regions that have been implicated in impulse control include the orbito-medial prefrontal cortex, right anterior cingulate, right anterior corona radiata, superior and inferior longitudinal fasciculus, limbic regions, basal ganglia, dorsolateral-prefrontal cortex, cerebellar vermis, caudate nucleus, prefrontal cortex white matter and corpus callosum. (12)
Neurobiological explanations for hyperactive behavior in ADHD suggest that changes in brain chemistry may also play a role. For example, ADHD is associated with deficits in two main neurotransmitters: dopamine and norepinephrine. These neurotransmitters are involved in impulse control, focus, decision-making, emotion regulation, and reward processing. ADHD may also affect the levels of serotonin, another neurotransmitter that influences brain function. (13)
Overall, the neural basis of hyperactivity and impulsivity in ADHD is complex and likely involves a combination of anatomical and functional changes in multiple brain regions as well as changes in brain chemistry. Further research is needed to fully understand the neurobiological mechanisms underlying these symptoms in ADHD.
2.2 Executive Functions and ADHD
Executive functions are a set of cognitive processes that are necessary for the cognitive control of behavior. These processes include working memory, cognitive flexibility, and inhibitory control. Working memory is the ability to hold and manipulate information in the mind over short periods of time. Cognitive flexibility is the ability to switch between different tasks or mental sets. Inhibitory control is the ability to suppress inappropriate responses or actions. (14) (15)
Individuals with ADHD often have impairments in executive functions. These impairments can manifest as difficulties with working memory, cognitive flexibility, and inhibitory control. For example, individuals with ADHD may have trouble remembering instructions, switching between tasks, or inhibiting impulsive behavior. (14) (15)
Neurocognitive research on executive function deficits in ADHD has helped to elucidate the underlying neurobiology of these impairments. Studies have shown that individuals with ADHD have differences in brain structure and function compared to individuals without ADHD. These differences may contribute to executive function deficits in ADHD. For example, neuroimaging studies have shown that individuals with ADHD have reduced activation in the prefrontal cortex, a brain region involved in executive functions, during tasks that require working memory or inhibitory control. (14) (15)
Overall, executive function deficits are a common feature of ADHD and can significantly impact daily functioning. Further research is needed to better understand the neurobiological mechanisms underlying these deficits and to develop effective interventions to improve executive function in individuals with ADHD.
3.1 Neurofeedback and ADHD Treatment
Neurofeedback is a type of biofeedback therapy that uses real-time displays of brain activity to teach self-regulation of brain function. During neurofeedback sessions, individuals with ADHD learn to control their brainwaves by receiving feedback on their brain activity in the form of visual or auditory cues. The goal of neurofeedback is to help individuals with ADHD improve their attention, impulse control, and other symptoms by training their brains to produce more desirable patterns of brain activity. (16)
Research on the effectiveness of neurofeedback for ADHD has yielded mixed results. Some studies have found that neurofeedback can lead to significant improvements in ADHD symptoms, while others have found no significant benefit. A meta-analysis of 13 studies found that neurofeedback was associated with moderate to large improvements in inattention and impulsivity/hyperactivity, as well as improvements in other areas such as academic performance and social skills. However, more research is needed to determine the long-term effectiveness of neurofeedback and to identify the most effective protocols. (16)
The potential benefits of neurofeedback for individuals with ADHD include improved attention, impulse control, and other symptoms. Neurofeedback is a non-invasive and drug-free approach, which may be appealing to individuals who prefer to avoid medication. However, there are also limitations to neurofeedback. Neurofeedback can be time-consuming and expensive, and it requires a high level of commitment from the individual. Additionally, the effectiveness of neurofeedback may vary depending on the individual and the specific protocol used. (16)
Overall, neurofeedback is a promising therapeutic approach for individuals with ADHD, but more research is needed to fully understand its effectiveness and potential benefits and limitations.
3.2 Medications and ADHD
Stimulant medications, such as Ritalin and Adderall, are commonly used to treat ADHD. These medications work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. These neurotransmitters play a role in attention, impulse control, and other executive functions. By increasing their levels, stimulant medications can help improve focus, reduce impulsivity, and decrease hyperactivity in individuals with ADHD. (17)
Stimulant medications have been shown to be effective in treating ADHD symptoms in many individuals. However, like all medications, they can have side effects and may not be effective for everyone. Common side effects of stimulant medications include decreased appetite, difficulty sleeping, and stomach upset. In rare cases, stimulant medications can cause more serious side effects such as increased heart rate and blood pressure. (17)
When considering medication management for ADHD, it is important to work closely with a healthcare provider to find the right medication and dosage. Medication management should also include regular monitoring for side effects and effectiveness. Additionally, medication is just one part of a comprehensive treatment plan for ADHD that may also include therapy, behavioral interventions, and lifestyle changes. (17)
Overall, stimulant medications can be an effective treatment option for many individuals with ADHD. However, it is important to carefully consider the potential benefits and risks and to work closely with a healthcare provider to manage medication use.
3.3 Lifestyle and Behavioral Interventions
There are several non-pharmacological approaches for managing ADHD, including changes to diet, exercise, and sleep habits, as well as behavioral therapy.
Diet can play a role in managing ADHD symptoms. Some research suggests that certain dietary changes, such as reducing sugar intake and increasing the consumption of omega-3 fatty acids, may help improve ADHD symptoms. However, more research is needed to fully understand the relationship between diet and ADHD. (18)
Exercise can also be beneficial for individuals with ADHD. Regular physical activity has been shown to improve focus, reduce impulsivity, and decrease hyperactivity in individuals with ADHD. Exercise may also help improve mood and reduce anxiety and depression, which are common co-occurring conditions in individuals with ADHD. (18)
Sleep is another important factor in managing ADHD symptoms. Many individuals with ADHD have difficulty falling or staying asleep, which can exacerbate their symptoms. Establishing a regular sleep routine and practicing good sleep hygiene can help improve sleep quality and reduce ADHD symptoms. (18)
Behavioral therapy is another non-pharmacological approach for managing ADHD. This type of therapy focuses on teaching individuals with ADHD skills to manage their behavior and improve their functioning. Behavioral therapy may involve techniques such as positive reinforcement, problem-solving, and goal-setting. Research has shown that behavioral therapy can be effective in reducing ADHD symptoms and improving functioning in individuals with ADHD. (18)
Overall, non-pharmacological approaches can be an important part of a comprehensive treatment plan for managing ADHD. It is important to work closely with a healthcare provider to develop an individualized treatment plan that addresses the specific needs of the individual with ADHD.
3.4 Future Directions in ADHD Research
There are several emerging trends and advancements in ADHD neuroscience that hold promise for improving our understanding of the disorder and developing more effective treatments. One such trend is the use of neuroimaging techniques to better understand the brain changes associated with ADHD. For example, researchers are using functional magnetic resonance imaging (fMRI) to study brain activity in individuals with ADHD, and diffusion tensor imaging (DTI) to investigate white matter changes in the brain. (19)
Another area of active research is the study of genetic factors that may contribute to the development of ADHD. Researchers are using techniques such as genome-wide association studies (GWAS) to identify genetic variations that may be associated with an increased risk of developing ADHD. This research may help to improve our understanding of the underlying biology of ADHD and could lead to the development of new treatments. (20)
In terms of treatment, there is growing interest in non-pharmacological approaches such as neurofeedback, cognitive training, and mindfulness-based interventions. These approaches aim to improve attention, impulse control, and other symptoms of ADHD by training the brain to function more effectively. While more research is needed to fully understand the effectiveness of these approaches, they hold promise as alternative or complementary treatments for ADHD. (21) Additionally, the use of mindfulness meditation as a treatment for ADHD, (22), and cognitive training as it is associated with significant improvements in ADHD symptoms, as well as improvements in working memory, inhibition, and other cognitive functions. (23)
Overall, there are many exciting developments in ADHD neuroscience that have the potential to improve our understanding of the disorder and lead to more effective treatments. Further research is needed to fully realize this potential, but the outlook for improved diagnosis and treatment of ADHD is promising.
Conclusion
ADHD, more than just a behavioral concern, is fundamentally a neurological disorder intricately linked to brain structure, chemistry, and function. Central to this understanding are neurotransmitter deficits, particularly in dopamine and norepinephrine, affecting impulse control, focus, and emotional regulation. Key brain regions involved include the prefrontal cortex and limbic system. Genetics contribute significantly to ADHD susceptibility, with an estimated 22% heritability rate, although environmental factors also play a role. Impairments in executive functions, such as working memory, are common among those with ADHD. Treatment encompasses a range of options, from neurofeedback and medication to behavioral therapy and lifestyle adjustments. The field continues to evolve, driven by ongoing research that explores neuroimaging, genetics, and innovative treatments, holding the promise of deeper insights and improved care for ADHD individuals.
References
“Symptoms and Diagnosis of ADHD.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 9 Aug. 2022, www.cdc.gov/ncbddd/adhd/diagnosis.html. (1)
“ADHD Facts and Statistics: Prevalence, Age of Onset, & Treatment.” The Recovery Village Drug and Alcohol Rehab, 7 May 2023, www.therecoveryvillage.com/mental-health/adhd/adhd-statistics/. (2)
Bing, Microsoft, bing.com/search?q=Common%2Bsymptoms%2Band%2Bchallenges%2Bassociated%2Bwith%2BADHD. (3)
“The Brain and ADHD: Neurotransmitters That May Cause Symptoms.” BetterHelp, www.betterhelp.com/advice/adhd/the-brain-and-adhd-neurotransmitters-that-may-cause-symptoms/. (4)
Gehricke, Jean-G., et al. “The Brain Anatomy of Attention-Deficit/Hyperactivity Disorder in Young Adults – a Magnetic Resonance Imaging Study.” PLOS ONE, Public Library of Science, journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0175433. (5)
Team, ADDA Editorial. “ADHD Causes: Is ADHD Genetic?” ADDA - Attention Deficit Disorder Association, 5 Jan. 2023, add.org/is-adhd-genetic/. (6)
Grimm, Oliver, et al. “Genetics of ADHD: What Should the Clinician Know? - Current Psychiatry Reports.” SpringerLink, Springer US, 27 Feb. 2020, link.springer.com/article/10.1007/s11920-020-1141-x. (7)
“Mapping Brain Circuits Involved in Attention.” National Institutes of Health, U.S. Department of Health and Human Services, 4 Aug. 2016, www.nih.gov/news-events/nih-research-matters/mapping-brain-circuits-involved-attention. (8)
“Brain Networks and Connectivity in ADHD.” ADxS.Org, www.adxs.org/en/page/158/brain-networks-and-connectivity-in-adhd. (9)
Lin, Huang, et al. “Population Level Multimodal Neuroimaging Correlates of Attention-Deficit Hyperactivity Disorder among Children.” Frontiers, Frontiers, 7 Feb. 2023, www.frontiersin.org/articles/10.3389/fnins.2023.1138670/full. (10)
Saad, Jacqueline Fifi, et al. “A Systematic Review of Imaging Studies in the Combined and Inattentive Subtypes of Attention Deficit Hyperactivity Disorder.” Frontiers, Frontiers, 7 May 2020, www.frontiersin.org/articles/10.3389/fnint.2020.00031/full. (11)
“Neurobiology of Attention Deficit Hyperactivity Disorder (ADHD) - A Primer.” Psych Scene Hub, 4 Mar. 2023, psychscenehub.com/psychinsights/neurobiology-of-adhd/. (12)
“ADHD: Is It a Neurological Disorder?” Medical News Today, MediLexicon International, www.medicalnewstoday.com/articles/is-adhd-a-neurological-disorder. (13)
“Adult ADHD: Symptoms, Diagnosis, and Treatment.” Medical News Today, MediLexicon International, www.medicalnewstoday.com/articles/adult-adhd. (14)
“Attention-Deficit/Hyperactivity Disorder (ADHD) in Children.” Mayo Clinic, Mayo Foundation for Medical Education and Research, 25 June 2019, www.mayoclinic.org/diseases-conditions/adhd/symptoms-causes/syc-20350889. (15)
“Attention Deficit Hyperactivity Disorder | ADHD | ADD.” MedlinePlus, U.S. National Library of Medicine, medlineplus.gov/attentiondeficithyperactivitydisorder.html. (16)
“Mental Health Minute: Attention-Deficit/Hyperactivity Disorder.” National Institute of Mental Health, U.S. Department of Health and Human Services, www.nimh.nih.gov/news/media/2021/mental-health-minute-attention-deficit-hyperactivity-disorder. (17)
Attention Deficit Hyperactivity Disorder (ADHD) - World Health Organization, applications.emro.who.int/docs/EMRPUB_leaflet_2019_mnh_214_en.pdf?ua=1&ua=1. (18)
G;, Bush. “Neuroimaging of Attention Deficit Hyperactivity Disorder: Can New Imaging Findings Be Integrated in Clinical Practice?” Child and Adolescent Psychiatric Clinics of North America, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/18295152/. (19)
Mirkovic, Bojan, et al. “Epigenetics and Attention-Deficit/Hyperactivity Disorder: New Perspectives?” Frontiers, Frontiers, 5 June 2020, www.frontiersin.org/articles/10.3389/fpsyt.2020.00579/full. (20)
D;, Holtmann M;Sonuga-Barke E;Cortese S;Brandeis. “Neurofeedback for ADHD: A Review of Current Evidence.” Child and Adolescent Psychiatric Clinics of North America, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/25220087/. (21)
Cortese S;Ferrin M;Brandeis D;Buitelaar J;Daley D;Dittmann RW;Holtmann M;Santosh P;Stevenson J;Stringaris A;Zuddas A;Sonuga-Barke EJ; ; “Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes from Randomized Controlled Trials.” Journal of the American Academy of Child and Adolescent Psychiatry, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/25721181/. (22)
SH;, Mitchell JT;Zylowska L;Kollins. “Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.” Cognitive and Behavioral Practice, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/25908900/. (23)
Comments